On the eve of personalized medicine in oncology
Cancer Res
.
2008 Sep 15;68(18):7250-2.
doi: 10.1158/0008-5472.CAN-08-1374.
Authors
Timothy J Yeatman
1
,
James Mule
,
William S Dalton
,
Dan Sullivan
Affiliation
1
Total Cancer Care, H. Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. timothy.yeatman@moffitt.org
PMID:
18794109
PMCID:
PMC2650840
DOI:
10.1158/0008-5472.CAN-08-1374
No abstract available
Publication types
Congress
MeSH terms
Clinical Trials as Topic / methods
Humans
Medical Oncology / methods*
Neoplasms / drug therapy
Neoplasms / genetics*
Neoplasms / therapy*
Grants and funding
R01 CA098522/CA/NCI NIH HHS/United States
R01 CA098522-05/CA/NCI NIH HHS/United States
R01 CA112215/CA/NCI NIH HHS/United States
R01 CA112215-03/CA/NCI NIH HHS/United States